July 15, 2005
CORRECTED: Chiron sees less Begrivac flu vaccine
In Chicago story headlined, "Chiron sees less Begrivac flu
vaccine outside U.S.," please read in second paragraph, "Chiron
cut its supply ... by about 8 million doses" instead of,
"Chiron cut its supply ... to about 8 million doses." Corrects
number of doses cut.
A corrected version follows.
flu vaccine last season because of contamination problems in
its British plant, on Friday said it will supply less of its
Begrivac flu vaccine made in a German plant because of similar
Chiron cut its supply expectations for the vaccine by about
8 million doses and said it may delay shipments until early
October. Chiron had expected to supply about 12 million doses
to customers outside of the United States for the 2005-2006 flu
Chiron now expects to supply about 4 million doses of the
vaccine in these markets. The Begrivac vaccine is made at
Chiron's facility in Marburg, Germany.